365 studies found for:    "Squamous cell carcinoma of the head and neck"
Show Display Options
Rank Status Study
21 Unknown  Randomised Phase II, Cetuximab in Combination With 5FU and Cisplatin or Carboplatin Versus Cetuximab in Combination With Paclitaxel and Carboplatin for Treatment of Patients With Metastatic Squamous Cell Carcinoma of the Head and Neck
Condition: Squamous Cell Carcinoma of the Head and Neck
Intervention: Drug: Cetuximab
22 Active, not recruiting Docetaxel And Cisplatin With or Without Erlotinib For Metastatic Or Recurrent Squamous Cell Carcinoma Of Head And Neck
Conditions: Head and Neck Cancer;   Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: Cisplatin;   Drug: Docetaxel;   Drug: Erlotinib;   Other: Placebo;   Drug: Carboplatin
23 Recruiting Stereotactic Body Radiotherapy and Concurrent Cisplatin for Re-Irradiation of Unresectable, Recurrent Squamous Cell Carcinomas of Head and Neck
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: Cisplatin;   Radiation: Stereotactic Body Radiation Therapy (SBRT)
24 Completed Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Conditions: Advanced Squamous Cell Carcinoma;   Squamous Cell Carcinoma of Head and Neck;   SSCHN
Interventions: Drug: Docetaxel;   Drug: Cisplatin;   Drug: 5-Fluorouracil
25 Completed
Has Results
A Trial to Determine the Safety and Anti-tumor Activity Profile of the Combination of Cetuximab and Concomitant Cisplatin Plus 5-Fluorouracil (5-FU) in Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma in Head and Neck
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Biological: Cetuximab;   Drug: Cisplatin;   Drug: 5-Fluorouracil
26 Completed Head and Neck Phase III Iressa Versus Methotrexate Refractory: Iressa Versus Methotrexate (IMEX)
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: Gefitinib;   Drug: methotrexate
27 Recruiting SUPREME-HN A Retrospective Cohort Study of PD-L1 in Recurrent and Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)
Condition: Squamous Cell Carcinoma of the Head and Neck
Intervention:
28 Recruiting Valproic Acid Plus Cisplatin and Cetuximab in Recurrent and/or Metastatic Squamous Cell Carcinoma of Head and Neck
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: Valproic Acid;   Drug: Cisplatin;   Drug: Cetuximab
29 Terminated A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
Conditions: Urothelial Carcinoma;   Cholangiocarcinoma;   Cervical Cancer;   Squamous Cell Carcinoma of Head and Neck
Intervention: Drug: BIND-014 (docetaxel nanoparticles for injectable suspension)
30 Completed
Has Results
A Randomized Phase 2 Pharmacokinetic Trial of Chemotherapy With or Without Panitumumab in Patients With Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck
Condition: Squamous Cell Carcinoma of Head and Neck
Interventions: Drug: Panitumumab;   Drug: Cisplatin;   Drug: 5FU
31 Unknown  Pemetrexed as Salvage Treatment in Squamous Cell Carcinoma of Head and Neck
Condition: Squamous Cell Carcinoma of Head and Neck
Intervention: Drug: Pemetrexed
32 Terminated A Post Marketing Surveillance Study to Assess the Safety and Efficacy of Cetuximab Plus Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Conditions: Unresectable Locally Advanced Squamous Cell Carcinoma of Head and Neck;   LA SCCHN
Intervention: Drug: Cetuximab + RT
33 Recruiting Study of LEE011plus Cetuximab in Patients With a Cancer of the Head and Neck
Condition: Squamous Cell Carcinoma of the Head and Neck
Intervention: Drug: LEE011
34 Active, not recruiting Phase II Study of RAD001 Head and Neck Cancer
Condition: Squamous Cell Carcinoma of the Head and Neck
Intervention: Drug: Everolimus 10mg daily
35 Completed Chromoendoscopy to Detect Early Synchronous Second Primary Esophageal Carcinoma
Condition: Squamous Cell Carcinomas of the Head and Neck
Intervention: Procedure: Esophagoscopy and chromoendoscopy
36 Completed Cabazitaxel - PF Induction Chemotherapy
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: Cabazitaxel 10mg/m2;   Drug: Cabazitaxel 12.5mg/m2;   Drug: Cabazitaxel 15mg/m2;   Drug: Cabazitaxel 17.5mg/m2;   Drug: Cabazitaxel 20mg/m2
37 Active, not recruiting Study of DCA (Dichloroacetate) in Combination With Cisplatin and Definitive Radiation in Head and Neck Carcinoma
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: DCA (dichloroacetate);   Drug: Placebo
38 Unknown  Study of 3-Dimensional Conformal Radiotherapy (3D-CRT) Versus Intensity Modulated Radiotherapy (IMRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Radiation: 3 Dimensional Radiation Therapy;   Radiation: Intensity Modulated Radiation Therapy
39 Recruiting Weekly Carboplatin, Paclitaxel and Cetuximab Treatment for Patients With Recurrent or Metastatic SCCHN
Conditions: Head and Neck Cancer;   Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: Cetuximab;   Drug: Paclitaxel;   Drug: Carboplatin
40 Recruiting Cetuximab and Dasatinib in Recurrent Squamous Cell Carcinoma
Condition: Squamous Cell Carcinoma Of The Head And Neck
Interventions: Drug: Cetuximab;   Drug: Dasatinib

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years